Chow Tai Seng Jewellery Co., Ltd. (002867.SZ)
CNY 14.27
(0.28%)
CNY 14.27
(0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.79 Billion CNY | 23.53% |
| 2022 | 1.5 Billion CNY | -15.6% |
| 2021 | 1.66 Billion CNY | 32.48% |
| 2020 | 1.36 Billion CNY | 1.28% |
| 2019 | 1.35 Billion CNY | 15.1% |
| 2018 | 1.11 Billion CNY | 39.08% |
| 2017 | 820.29 Million CNY | 42.22% |
| 2016 | 585.88 Million CNY | 13.17% |
| 2015 | 503.07 Million CNY | 11.77% |
| 2014 | 449.12 Million CNY | 34.01% |
| 2013 | 341.31 Million CNY | 7.75% |
| 2012 | 331.73 Million CNY | 4.21% |
| 2011 | 303.95 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 468.8 Million CNY | 45.53% |
| 2024 Q3 | 336.92 Million CNY | -8.31% |
| 2024 Q2 | 389.27 Million CNY | -19.49% |
| 2023 Q4 | 336.55 Million CNY | -30.79% |
| 2023 FY | - CNY | 23.53% |
| 2023 Q2 | 463.04 Million CNY | -7.84% |
| 2023 Q3 | 486.25 Million CNY | 5.01% |
| 2023 Q1 | 502.44 Million CNY | 174.36% |
| 2022 Q4 | 183.12 Million CNY | -63.17% |
| 2022 Q3 | 497.23 Million CNY | 28.34% |
| 2022 Q2 | 387.44 Million CNY | 6.35% |
| 2022 Q1 | 364.31 Million CNY | -3.01% |
| 2022 FY | - CNY | -15.6% |
| 2021 Q4 | 375.63 Million CNY | -29.47% |
| 2021 FY | - CNY | 32.48% |
| 2021 Q1 | 312.22 Million CNY | -15.86% |
| 2021 Q2 | 500.42 Million CNY | 60.28% |
| 2021 Q3 | 532.62 Million CNY | 6.43% |
| 2020 Q2 | 287.08 Million CNY | 112.69% |
| 2020 FY | - CNY | 1.28% |
| 2020 Q4 | 371.07 Million CNY | -27.71% |
| 2020 Q3 | 513.29 Million CNY | 78.79% |
| 2020 Q1 | 134.97 Million CNY | -57.52% |
| 2019 Q2 | 362.5 Million CNY | 30.77% |
| 2019 Q1 | 277.2 Million CNY | -1.31% |
| 2019 FY | - CNY | 15.1% |
| 2019 Q4 | 317.73 Million CNY | -5.86% |
| 2019 Q3 | 337.5 Million CNY | -6.9% |
| 2018 FY | - CNY | 39.08% |
| 2018 Q2 | 290.11 Million CNY | 41.22% |
| 2018 Q4 | 280.86 Million CNY | -18.29% |
| 2018 Q3 | 343.75 Million CNY | 18.49% |
| 2018 Q1 | 205.42 Million CNY | -10.99% |
| 2017 Q1 | 155.22 Million CNY | -0.87% |
| 2017 FY | - CNY | 42.22% |
| 2017 Q2 | 196.78 Million CNY | 26.78% |
| 2017 Q4 | 230.77 Million CNY | 2.76% |
| 2017 Q3 | 224.57 Million CNY | 14.12% |
| 2016 FY | - CNY | 13.17% |
| 2016 Q2 | 154.42 Million CNY | 23.54% |
| 2016 Q4 | 156.58 Million CNY | 19.66% |
| 2016 Q3 | 130.85 Million CNY | -15.27% |
| 2016 Q1 | 125 Million CNY | 0.0% |
| 2015 FY | - CNY | 11.77% |
| 2014 Q2 | 109.1 Million CNY | 0.0% |
| 2014 Q1 | 109.1 Million CNY | 0.0% |
| 2014 FY | - CNY | 34.01% |
| 2013 FY | - CNY | 7.75% |
| 2012 FY | - CNY | 4.21% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Guangdong Chj Industry Co.,Ltd. | 532.37 Million CNY | -236.882% |
| Innovation Medical Management Co., Ltd. | 75.34 Million CNY | -2280.505% |
| Beijing Kingee Culture Development Co., Ltd. | 1.01 Billion CNY | -76.358% |